Leonilda Bilo

Prof. Dr. Leonilda Bilo

orcid

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1988 in Epilepsia
Verified
Journal Article
Closed access
PDF file
LBLeonilda Bilo
Leonilda Bilo
RMRoberta Meo
Roberta Meo
CNCarmine Nappi
Carmine Nappi
LALUCIO ANNUNZIATO
LUCIO ANNUNZIATO
SSSalvatore Striano
Salvatore Striano
GBGiuseppe Andrea Buscaino
Giuseppe Andrea Buscaino

5 July 2016 in Neurology
Verified
Journal Article
Open access
PDF file
SBSimona Balestrini
Simona Balestrini
MMMathieu Milh
Mathieu Milh
CCClaudia Castiglioni
Claudia Castiglioni
KLKevin Lüthy
Kevin Lüthy
Mattéa FinelliMattéa Finelli
Mattéa Finelli
SSS.M. Sisodiya
S.M. Sisodiya
Objective: To evaluate the phenotypic spectrum associated with mutations in TBC1D24. Methods: We acquired new clinical, EEG, and neuroimaging data of 11 previously unreported and 37 published patients. TBC1D24 mutations, identified through various sequencing methods, can be found online (http://lovd.nl/TBC1D24). Results: Forty-eight patients were included (28 men, 20 women, average age 21 years) from 30 independent families. Eighteen patients (38%) had myoclonic epilepsies. The other patients carried diagnoses of focal (25%), multifocal (2%), generalized (4%), and unclassified epilepsy (6%), and early-onset epileptic encephalopathy (25%). Most patients had drug-resistant epilepsy. We detail EEG, neuroimaging, developmental, and cognitive features, treatment responsiveness, and physical examination. In silico evaluation revealed 7 different highly conserved motifs, with the most common pathogenic mutation located in the first. Neuronal outgrowth assays showed that some TBC1D24 mutations, associated with the most severe TBC1D24-associated disorders, are not necessarily the most disruptive to this gene function. Conclusions: TBC1D24-related epilepsy syndromes show marked phenotypic pleiotropy, with multisystem involvement and severity spectrum ranging from isolated deafness (not studied here), benign myoclonic epilepsy restricted to childhood with complete seizure control and normal intellect, to early-onset epileptic encephalopathy with severe developmental delay and early death. There is no distinct correlation with mutation type or location yet, but patterns are emerging. Given the phenotypic breadth observed, TBC1D24 mutation screening is indicated in a wide variety of epilepsies. A TBC1D24 consortium was formed to develop further research on this gene and its associated phenotypes.

1 April 1991 in Fertility and Sterility
Verified
Journal Article
Closed access
LBLeonilda Bilo
Leonilda Bilo
RMRoberta Meo
Roberta Meo
RVRossella Valentino
Rossella Valentino
GBGiuseppe A. Buscaino
Giuseppe A. Buscaino
SSSalvatore Striano
Salvatore Striano
CNCarmine Nappi
Carmine Nappi

1 November 2002 in Neurophysiologie Clinique
Verified
Journal Article
Closed access
SSSalvatore Striano
Salvatore Striano
PSPasquale Striano
Pasquale Striano
CNCristofaro Nocerino
Cristofaro Nocerino
PBPatrizia Boccella
Patrizia Boccella
LBLeonilda Bilo
Leonilda Bilo
PRPatrizia Ruosi
Patrizia Ruosi

1 January 2008 in Gynecological Endocrinology
Verified
Journal Article
Closed access
LBLeonilda Bilo
Leonilda Bilo
RMRoberta Meo
Roberta Meo
Valproate (VPA) is a highly effective drug successfully employed in several neuropsychiatric diseases. In the last 15 years, an increased prevalence of polycystic ovary syndrome (PCOS) associated with VPA use has been reported in both women with epilepsy and women with bipolar disorders. However, data on this subject are contrasting and it is possible that different factors might play a role in the development of PCOS in these patients. The risk of developing PCOS during VPA treatment seems to be higher in women with epilepsy than in women with bipolar disorders, and this might be due to an underlying neuroendocrine dysfunction related to the seizure disorder. Gynecologists must be aware of the possibility that PCOS in these populations of patients might be related to VPA use, and a careful multi-specialist approach is required for evaluating the risks and benefits of this treatment in the presence of features of PCOS.

1 March 2009 in Stroke
Verified
Journal Article
Closed access
PDF file
RSRossana Sirabella
Rossana Sirabella
Agnese SecondoAgnese Secondo
Agnese Secondo
APAnna Pannaccione
Anna Pannaccione
ASAntonella Scorziello
Antonella Scorziello
VVValeria Valsecchi
Valeria Valsecchi
LALUCIO ANNUNZIATO
LUCIO ANNUNZIATO
Background and Purpose— The 3 gene products of the Na + /Ca 2+ exchanger (NCX), viz, NCX1, NCX2, and NCX3, may play a pivotal role in the pathophysiology of brain ischemia. The aim of this study was to investigate the transductional and posttranslational mechanisms involved in the expression of these isoforms during oxygen and glucose deprivation and their role in endoplasmic reticulum Ca 2+ refilling in cortical neurons. Methods— NCX1, NCX2, and NCX3 transcript and protein expression was evaluated in primary cortical neurons by reverse transcriptase–polymerase chain reaction and Western blot. NCX currents (I NCX ) and cytosolic Ca 2+ concentrations ([Ca 2+ ] i ) were monitored by means of patch-clamp in whole-cell configuration and Fura-2AM single-cell video imaging, respectively. Results— Exposure of cortical neurons to 3 hours of oxygen and glucose deprivation yielded dissimilar effects on the 3 isoforms. First, it induced an upregulation in NCX1 transcript and protein expression. This change was exerted at the transcriptional level because the inhibition of nuclear factor kappa B translocation by small interfering RNA against p65 and SN-50 prevented oxygen and glucose deprivation-induced NCX1 upregulation. Second, it elicited a downregulation of NCX3 protein expression. This change, unlike NCX1, was exerted at the posttranscriptional level because it was prevented by the proteasome inhibitor MG-132. Finally, we found that it significantly increased I NCX both in the forward and reverse modes of operation and promoted an increase in ER Ca 2+ accumulation. Interestingly, such accumulation was prevented by the silencing of NCX1 and the NCX inhibitor CB-DMB that triggered caspase-12 activation. Conclusions— These results suggest that nuclear factor kappa B-dependent NCX1 upregulation may play a fundamental role in Ca 2+ refilling in the endoplasmic reticulum, thus helping neurons to prevent endoplasmic reticulum stress during oxygen and glucose deprivation.